Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wahl

Showing results (781-790 of 851) with videos related to

Pageof 86
Sort By:
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1977
Obtaining, evaluation and clinical application of antileukemic antilymphocyte globulin (ALLG) in the treatment of chronic lymphatic leukemiaB Bratkowska-Seniów, J Dziedzic, T Kaniak, et al.
Nature Medicine|October 4, 2000
Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healingG S Ashcroft, K Lei, W Jin, et al.
Nature Genetics|January 23, 1999
Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotypeX R Jiang, G Jimenez, E Chang, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 18, 2011
Systemic and mucosal differences in HIV burden, immune, and therapeutic responsesSharon M Wahl, Maryann Redford, Shawna Christensen, et al.
Hybridoma|January 1, 1985
The generation of stable human T-cell hybridomas which constitutively produce interleukin-2 and chemotactic factorK A Foon, J L Rossio, R W Schroff, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1988
IgG subclass-associated affinity differences of specific antibodies in humansM A Persson, S E Brown, M W Steward, et al.
Journal of Leukocyte Biology|April 29, 2015
The inhibitory effect of secretory leukocyte protease inhibitor (SLPI) on formation of neutrophil extracellular trapsKatarzyna Zabieglo, Pawel Majewski, Monika Majchrzak-Gorecka, et al.
American Journal of Epidemiology|May 15, 2012
Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System, 2009-2010W Katherine Yih, Grace M Lee, Tracy A Lieu, et al.
The Journal of Infectious Diseases|March 29, 2012
Host gene expression changes correlating with anti-HIV-1 effects in human subjects after treatment with peginterferon Alfa-2aJonathan J Hubbard, Teresa Greenwell-Wild, Lisa Barrett, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2002
NB2001, a novel antibacterial agent with broad-spectrum activity and enhanced potency against beta-lactamase-producing strainsQing Li, Jean Y Lee, Rosario Castillo, et al.
Pageof 86

Showing results (781-790 of 851) with videos related to

Sort By:
Pageof 86
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1977
Obtaining, evaluation and clinical application of antileukemic antilymphocyte globulin (ALLG) in the treatment of chronic lymphatic leukemiaB Bratkowska-Seniów, J Dziedzic, T Kaniak, et al.
Nature Medicine|October 4, 2000
Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healingG S Ashcroft, K Lei, W Jin, et al.
Nature Genetics|January 23, 1999
Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotypeX R Jiang, G Jimenez, E Chang, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 18, 2011
Systemic and mucosal differences in HIV burden, immune, and therapeutic responsesSharon M Wahl, Maryann Redford, Shawna Christensen, et al.
Hybridoma|January 1, 1985
The generation of stable human T-cell hybridomas which constitutively produce interleukin-2 and chemotactic factorK A Foon, J L Rossio, R W Schroff, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1988
IgG subclass-associated affinity differences of specific antibodies in humansM A Persson, S E Brown, M W Steward, et al.
Journal of Leukocyte Biology|April 29, 2015
The inhibitory effect of secretory leukocyte protease inhibitor (SLPI) on formation of neutrophil extracellular trapsKatarzyna Zabieglo, Pawel Majewski, Monika Majchrzak-Gorecka, et al.
American Journal of Epidemiology|May 15, 2012
Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System, 2009-2010W Katherine Yih, Grace M Lee, Tracy A Lieu, et al.
The Journal of Infectious Diseases|March 29, 2012
Host gene expression changes correlating with anti-HIV-1 effects in human subjects after treatment with peginterferon Alfa-2aJonathan J Hubbard, Teresa Greenwell-Wild, Lisa Barrett, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2002
NB2001, a novel antibacterial agent with broad-spectrum activity and enhanced potency against beta-lactamase-producing strainsQing Li, Jean Y Lee, Rosario Castillo, et al.
Pageof 86